Rituximab as maintenance therapy for ANCA-associated vasculitides: pooled analysis and long-term outcome of 277 patients included in the MAINRITSAN trialsFlorence Delestre, Pierre Charles, Alexandre Karras, Christian Pagnoux, Antoine Néel, Pascal Cohen, Olivier Aumaître, Stanislas Faguer, Pierre Gobert, François Maurier, Maxime Samson, Pascal Godmer, Bernard Bonnotte, Vincent Cottin, Catherine Hanrotel-SaliouSee the full list of authors
2 November 2023
Efficacy and safety of avacopan in patients with ANCA-associated vasculitis receiving rituximab in a randomised trialDuvuru Geetha, Anisha Dua, Huibin Yue, Jason Springer, Carlo Salvarani, David Jayne, Peter Merkel, , ADVOCATE Study Group, C. Au Peh, A. Chakera, B. Cooper, J. Kurtkoti, D. Langguth, V. LevidiotisSee the full list of authors
18 November 2023
Short-term effectiveness and safety of rituximab versus cyclophosphamide for life-threatening ANCA-associated vasculitis: a propensity score analysis of the real-world nationwide databaseYuichi Ishikawa, Kei Tokutsu, Shingo Nakayamada, Aya Kuchiba, Kiyohide Fushimi, Shinya Matsuda, Yoshiya Tanaka
19 September 2023
Reduced-dose versus high-dose glucocorticoids added to rituximab on remission induction in ANCA-associated vasculitis: predefined 2-year follow-up studyShunsuke Furuta, Daiki Nakagomi, Yoshihisa Kobayashi, Masaki Hiraguri, Takao Sugiyama, Koichi Amano, Takeshi Umibe, Hajime Kono, Kazuhiro Kurasawa, Yasuhiko Kita, Ryutaro Matsumura, Yuko Kaneko, Keita Ninagawa, Keiju Hiromura, Shin-ichiro KagamiSee the full list of authors
21 September 2023
Data quality and patient characteristics in European ANCA-associated vasculitis registries: data retrieval by federated queryingKarl Gisslander, Matthew Rutherford, Louis Aslett, Neil Basu, François Dradin, Lucy Hederman, Zdenka Hruskova, Hicham Kardaoui, Peter Lamprecht, Sabina Lichołai, Jacek Musial, Declan O’Sullivan, Xavier Puechal, Jennifer Scott, Mårten SegelmarkSee the full list of authors
31 October 2023
Benralizumab for eosinophilic granulomatosis with polyangiitisAdrien Cottu, Matthieu Groh, Charlene Desaintjean, Sylvain Marchand-Adam, Loïc Guillevin, Xavier Puechal, Stacy Beaumesnil, Estibaliz Lazaro, Maxime Samson, Camille Taille, Cécile-Audrey Durel, Elizabeth Diot, Sarah Nicolas, Laurent Guilleminault, Mikael EbboSee the full list of authors
7 August 2023
Dupilumab for relapsing or refractory sinonasal and/or asthma manifestations in eosinophilic granulomatosis with polyangiitis: a European retrospective studyBerengere Molina, Roberto Padoan, Maria Letizia Urban, Pavel Novikov, Marco Caminati, Camille Taillé, Antoine Néel, Laurence Bouillet, Paolo Fraticelli, Nicolas Schleinitz, Christine Christides, Laura Moi, Bertrand Godeau, Ann Knight, Jan Walter SchroederSee the full list of authors
21 September 2023
Incidence of primary large vessel vasculitis in Norfolk, UK from 2011 to 2020Chetan B Mukhtyar, Clare Beadsmoore, Fiona L Coath, Georgina Ducker, Sarah Fordham, Katherine Sisson, Cee Y Yong, Richard A Watts
30 June 2023
Age at diagnosis influences the clinical phenotype, treatment strategies and outcomes in patients with giant cell arteritis: results from the observational GCAGE study on a large cohort of 1004 patientsSara Monti, Alessandra Milanesi, Catherine Klersy, Alessandro Tomelleri, Lorenzo Dagna, Corrado Campochiaro, Nicola Farina, Francesco Muratore, Elena Galli, Chiara Marvisi, Milena Bond, Alvise Berti, Roberto Bortolotti, Roberto Padoan, Franco SchiavonSee the full list of authors
15 May 2023
Rituximab versus azathioprine for maintenance of remission for patients with ANCA-associated vasculitis and relapsing disease: an international randomised controlled trialRona M Smith, Rachel B Jones, Ulrich Specks, Simon Bond, Marianna Nodale, Reem Al-jayyousi, Jacqueline Andrews, Annette Bruchfeld, Brian Camilleri, Simon Carette, Chee Kay Cheung, Vimal Derebail, Tim Doulton, Alastair Ferraro, Lindsy ForbessSee the full list of authors
23 March 2023
